Planta Med 2011; 77(18): 2042-2046
DOI: 10.1055/s-0031-1280096
Natural Product Chemistry
Letters
© Georg Thieme Verlag KG Stuttgart · New York

Three New Phenolic Compounds from the Lichen Thamnolia vermicularis and Their Antiproliferative Effects in Prostate Cancer Cells

Jia Guo1 , 2 , Zhan-lin Li1 , 2 , Ao-li Wang1 , 2 , Xiao-qiu Liu2 , Jian Wang1 , 5 , Xin Guo3 , Yong-kui Jing4 , Hui-ming Hua1 , 2
  • 1Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, P. R. China
  • 2School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, P. R. China
  • 3School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, P. R. China
  • 4Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
  • 5School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, P. R. China
Further Information

Publication History

received February 22, 2011 revised June 17, 2011

accepted June 28, 2011

Publication Date:
27 July 2011 (online)

Abstract

Three new phenolic compounds, thamnoliadepsides A (1), B (2), and thamnolic acid A (3), and seven known compounds, everninic acid (4), baeomycesic acid (5), β-orcinol (6), β-resorcylic acid (7), ethyl orsellinate (8), squamatic acid (9), and vermicularin (10), were isolated from the lichen Thamnolia vermicularis (Sw.) Ach. ex Schaerer. Their structures were determined based on spectroscopic analysis, including 2D-NMR experiments and HR-MS techniques. Compound 1 inhibited growth of prostate cancer cells and bonded to G-quadruplex DNA based on NMR determination.

Supporting Information

References

  • 1 Sun H D, Shen X Y. The structure of vermicularin.  Acta Bot Yunn. 1985;  7 109-113
  • 2 Jiang B, Sun H D. Constituents from Thamnolia vermicularis.  Acta Bot Yunn. 2002;  24 525-530
  • 3 Haraldsdottir S, Guolaugsdottir E, Ingolfsdottir K, Ogmundsdottir H M. Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro.  Planta Med. 2004;  70 1098-1100
  • 4 Li B, Sun H D. The chemical constituents of four lichens from China.  Acta Bot Yunn. 1991;  13 81-84
  • 5 Cresp T M, Djura P, Sargent M V, Elix J A, Engkaninan U, Murphy D P H. The synthesis of notatic acid and 4-O-methylhypoprotocetraric acid.  Aust J Chem. 1975;  28 2417-2434
  • 6 Nishitoba Y, Nishimura H, Nishiyaya T, Mizutani J. Lichen acids, plant growth inhibitors from Usnea longissima.  Phytochemistry. 1987;  26 3181-3185
  • 7 Feng J, Yang X W, Su S D, He C. Studies on chemical constituents from herbs of Usnea longissima.  Chin J Chin Mater Med. 2009;  34 708-711
  • 8 Sun H D, Shen X Y. Studies on 13C-NMR of depside.  Acta Bot Yunn. 1992;  14 445-452
  • 9 Athukoralage P S, Herath H M, Deraniyagala S A, Wijesundera R L, Weerasinghe P A. Antifungal constituent from Gordonia dassanayakei.  Fitoterapia. 2001;  72 565-567
  • 10 Jiang B, Zhao Q S, Yang H, Hou A J, Lin Z W, Sun H D. Constituents from Lethariella cladonioides.  Fitoterapia. 2001;  72 832-833
  • 11 Bucar F, Schneider I, Gmundsdottir H O, Ingolfsdottir K. Anti-proliferative lichen compounds with inhibitory activity on 12(S)-HETE production in human platelets.  Phytomedicine. 2004;  11 602-606
  • 12 Kerwin S M. G-Quadruplex DNA as a target for drug design.  Curr Pharm Des. 2000;  6 441-471
  • 13 Cuesta J, Read M A, Neidle S. The design of G-quadruplex ligands as telomerase inhibitors.  Mini Rev Med Chem. 2003;  3 11-21
  • 14 Monchaud D, Teulade-Fichou M P. A hitchhiker's guide to G-quadruplex ligands.  Org Biomol Chem. 2008;  6 627-636
  • 15 Sun H X, Tang Y L, Xiang J F, Xu G Z, Zhang Y Z, Zhang H, Xu L H. Spectroscopic studies of the interaction between quercetin and G-quadruplex DNA.  Bioorg Med Chem Lett. 2006;  16 3586-3589
  • 16 Han H Y, Hurley L H. G-quadruplex DNA: a potential target for anti-cancer drug design.  Trends Pharmacol Sci. 2000;  21 136-142
  • 17 Hurley L H, Wheelhouse R T, Sun D, Kerwin S M, Salazar M, Fedoroff O Y, Han F X, Han H Y, Izbicka E, Von Hoff D D. G-quadruplexes as targets for drug design.  Pharmacol Ther. 2000;  85 141-158
  • 18 Neidle S, Read M A. G-quadruplexes as therapeutic targets.  Biopolymers 2000 –. 2001;  56 195-208
  • 19 Sun D, Thompson B, Cathers B E, Salazar M, Kerwin S M, Trent J O, Jenkins T C, Neidle S, Hurley L H. Inhibition of human telomerase by a G-quadruplex-interactive compound.  J Med Chem. 1997;  40 2113-2116
  • 20 Riou J F, Guittat L, Mailliet P, Laoui A, Renou E, Petitgenet O, Megnin-Chanet F, Helene C, Mergny J L. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands.  PNAS. 2002;  99 2672-2677
  • 21 Zhou Q J, Li L, Xiang J F, Tang Y L, Zhang H, Yang S, Li Q, Yang Q F, Xu G Z. Screening potential antitumor agents from natural plant extracts by G-quadruplex recognition and NMR methods.  Angew Chem Int Ed. 2008;  47 5590-5592
  • 22 Yang X, Liu G, Li H, Zhang Y, Song D, Li C, Wang R, Liu B, Liang W, Jing Y K, Zhao G. Novel oxadiazole analogues derived from ethacrynic acid: design, synthesis, and structure-activity relationships in inhibiting the activity of glutathione S-transferase P1-1 and cancer cell proliferation.  J Med Chem. 2010;  53 1015-1022
  • 23 Sun H X, Tang Y L, Xiang J F, Xu G Z. Regulation and recognization of the extended G-quadruplex by rutin.  Biochem Biophys Res Commun. 2007;  352 942-946

Prof. Dr. Hui-ming Hua

Key Laboratory of Structure-Based Drug Design & Discovery
Ministry of Education
School of Traditional Chinese Materia Medica
Shenyang Pharmaceutical University

Box 49

Shenyang 110016

People's Republic of China

Phone: +86 24 23 98 64 65

Fax: +86 24 23 98 64 65

Email: huimhua@163.com

>